Asialoglycoprotein - conjugated medicinal agent
AssigneeKorea Green Cross Corporation
InventorsChung Y. Kim, Hyo S. Lee
Life of this patent
Estimating the term…
Loading patent…
AssigneeKorea Green Cross Corporation
InventorsChung Y. Kim, Hyo S. Lee
Estimating the term…
The present invention relates to a conjugated medicinal agent prepared by combining asialoglycoprotein with a medicine which acts specifically on the liver. The conjugated medicinal agent of the present invention has the following formula (1): P-(S)x-Gal-GA-R, wherein in the P-(S)x-moiety, P is a peptide residue of a human serum glycoprotein and S is a sugar residue of a human serum glycoprotein; Gal is galactose residue; GA is glutaraldehyde residue; x is an integer equal to or greater than 1; and R is a medicinal component selected from the group consisting of interferon, acyclovir sodium, ribavirin, vidarabine, zidovudine, suramin, anti-sense oligonucleotide, ribozyme, leucovorin calcium, sodium-meglumine diatrizoate, gadolinium-DTPA, glutathione (GSH), prostaglandins, .sup.99m Tc and .sup.131 I. The present invention also includes a process for preparing the conjugated medicinal agent of formula (I), a pharmaceutical composition containing the conjugated medicine and the use of the conjugated medicine.
The asialoglycoprotein-conjugated medicinal agent having the following formula (1),
A process for preparing a conjugated interferon of formula (1)
A process for preparing a conjugated interferon of formula (1)
Dependencies are inferred from the claim text.